Charles R. Lambert - 24 Sep 2025 Form 4 Insider Report for MEDICAL PROPERTIES TRUST INC (MPW)

Role
SVP of Finance and Treasurer
Signature
W. Zachary Riddle, by power of attorney
Issuer symbol
MPW
Transactions as of
24 Sep 2025
Net transactions value
$0
Form type
4
Filing time
26 Sep 2025, 17:29:10 UTC
Previous filing
08 Jul 2025
Next filing
07 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LAMBERT CHARLES R SVP of Finance and Treasurer 1000 URBAN CENTER DRIVE, SUITE 501, BIRMINGHAM W. Zachary Riddle, by power of attorney 26 Sep 2025 0001225492

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MPW Common stock, par value $0.001 Award $0 +45,956 +18% $0.000000 304,590 24 Sep 2025 Direct F1
transaction MPW Common stock, par value $0.001 Award $0 +19,275 +6.3% $0.000000 323,865 24 Sep 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares vest at the beginning of each calendar quarter ending March 31, 2028.
F2 The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).
F3 Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.